Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer

NCT06173726 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced/Metastatic Liver Cancer

Interventions

BIOLOGICAL: BST02 Injection

Sponsor

BioSyngen Pte Ltd

Collaborators

[object Object]